1. Medication and medical equipment shortages harm US patients

   News item 04 November 2023 Pages: 1 - 1

2. Medicinal cannabis-related AEs

   News item 04 November 2023 Pages: 2 - 2

3. Overdose with off-label use of baclofen may lead to suicidal ideation

   News item 04 November 2023 Pages: 3 - 3

4. PRAC concludes GLP-1 receptor agonists not associated with thyroid cancer

   News item 04 November 2023 Pages: 4 - 4

5. Unapproved probiotics illegally sold for use in hospitalised preterm infants

   News item 04 November 2023 Pages: 5 - 5

6. Updated FDA labelling recommendations for biosimilars

   News item 04 November 2023 Pages: 6 - 6

7. BP elevation does not increase risk of MACE during VEGF TKI therapy

   Clinical study 04 November 2023 Pages: 7 - 7

8. Dupilumab in patients with atopic dermatitis: risk of ocular surface disease

   Clinical study 04 November 2023 Pages: 8 - 8

9. Females report more AEFIs after influenza vaccination

   Clinical study 04 November 2023 Pages: 9 - 9

10. Incorrect use of smart infusion pumps causes medication errors in NICU

    Clinical study 04 November 2023 Pages: 10 - 10

11. Pfizer-BioNTech COVID-19 vaccination safe in adolescents with CKD

    Clinical study 04 November 2023 Pages: 11 - 11

12. Renal failure increases risk of severe trifluridine/tipiracil-related AEs

    Clinical study 04 November 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 04 November 2023 Pages: 13 - 13

14. Abemaciclib/dexamethasone/methotrexate

    Case report 04 November 2023 Pages: 14 - 14

15. Abemaciclib/ribociclib

    Case report 04 November 2023 Pages: 15 - 15

16. Adalimumab/azathioprine

    Case report 04 November 2023 Pages: 16 - 16

17. Adalimumab/infliximab

    Case report 04 November 2023 Pages: 17 - 17

18. Adalimumab/infliximab/mesalazine

    Case report 04 November 2023 Pages: 18 - 18

19. Alectinib/lorlatinib

    Case report 04 November 2023 Pages: 19 - 19

20. Amantadine

    Case report 04 November 2023 Pages: 20 - 20

21. Amiodarone

    Case report 04 November 2023 Pages: 21 - 21

22. Amiodarone/mexiletine

    Case report 04 November 2023 Pages: 22 - 22

23. Amisulpride

    Case report 04 November 2023 Pages: 23 - 23

24. Amlodipine/methyldopa

    Case report 04 November 2023 Pages: 24 - 24

25. Amoxicillin

    Case report 04 November 2023 Pages: 25 - 25

26. Amoxicillin

    Case report 04 November 2023 Pages: 26 - 26

27. Amphotericin-B-liposomal/Antibacterials

    Case report 04 November 2023 Pages: 27 - 27

28. Anakinra/tocilizumab

    Case report 04 November 2023 Pages: 28 - 28

29. Analgesics

    Case report 04 November 2023 Pages: 29 - 29

30. Analgesics/antineoplastics/benzodiazepinones

    Case report 04 November 2023 Pages: 30 - 30

31. Analgesics/pantoprazole

    Case report 04 November 2023 Pages: 31 - 31

32. Antibacterials

    Case report 04 November 2023 Pages: 32 - 32

33. Antibacterials/antifungals

    Case report 04 November 2023 Pages: 33 - 33

34. Antiepileptic-drugs

    Case report 04 November 2023 Pages: 34 - 34

35. Antiepileptic-drugs/tozinameran

    Case report 04 November 2023 Pages: 35 - 35

36. Antihistamines/hydrocortisone/methotrexate

    Case report 04 November 2023 Pages: 36 - 36

37. Antineoplastics

    Case report 04 November 2023 Pages: 37 - 37

38. Antineoplastics

    Case report 04 November 2023 Pages: 38 - 38

39. Antineoplastics

    Case report 04 November 2023 Pages: 39 - 39

40. Antineoplastics

    Case report 04 November 2023 Pages: 40 - 40

41. Antineoplastics

    Case report 04 November 2023 Pages: 41 - 41

42. Antineoplastics

    Case report 04 November 2023 Pages: 42 - 42

43. Antineoplastics

    Case report 04 November 2023 Pages: 43 - 43

44. Antineoplastics

    Case report 04 November 2023 Pages: 44 - 44

45. Antineoplastics

    Case report 04 November 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 04 November 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 04 November 2023 Pages: 47 - 47

48. Antineoplastics/diazoxide

    Case report 04 November 2023 Pages: 48 - 48

49. Antineoplastics/folinic acid

    Case report 04 November 2023 Pages: 49 - 49

50. Antineoplastics/hydrocortisone-sodium-succinate

    Case report 04 November 2023 Pages: 50 - 50